Dynamic Technology Lab’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-22,600
Closed -$640K 1034
2025
Q3
$640K Buy
22,600
+8,596
+61% +$257K 0.11% 321
2025
Q2
$262K Sell
14,004
-13,113
-48% -$249K 0.04% 726
2025
Q1
$488K Buy
+27,117
New +$550K 0.07% 493
2024
Q2
Sell
-1,810
Closed -$27K 1309
2024
Q1
$27K Buy
+1,810
New +$24.4K ﹤0.01% 999
2022
Q4
Sell
-7,846
Closed -$93K 1454
2022
Q3
$93K Buy
+7,846
New +$106K 0.01% 1025
2021
Q2
Sell
-6,368
Closed -$218K 1467
2021
Q1
$218K Buy
+6,368
New +$252K 0.02% 917
2020
Q3
Sell
-7,739
Closed -$142K 1289
2020
Q2
$142K Buy
+7,739
New +$139K 0.02% 852
2019
Q3
Sell
-2,956
Closed -$77K 1239
2019
Q2
$77K Sell
2,956
-1,747
-37% -$39.4K 0.01% 888
2019
Q1
$121K Buy
4,703
+1,109
+31% +$25.4K 0.02% 883
2018
Q4
$83K Buy
3,594
+1,010
+39% +$28.5K 0.01% 905
2018
Q3
$83K Buy
2,584
+844
+49% +$25.3K 0.01% 962
2018
Q2
$50K Buy
+1,740
New +$61.9K 0.01% 929
2015
Q4
Sell
-1,567
Closed -$39K 1076
2015
Q3
$39K Buy
+1,567
New +$46.8K 0.01% 771
2015
Q2
Sell
-2,621
Closed -$96K 916
2015
Q1
$96K Buy
+2,621
New +$71.9K 0.04% 605

Other funds holding RIGL

Dynamic Technology Lab's RIGL Position: Q4 2025 in Review

Dynamic Technology Lab sold out of Rigel Pharmaceuticals (RIGL) in Q4 2025, closing a stake of 22,600 shares — an estimated $640K sold.

Dynamic Technology Lab first reported a position in RIGL in Q1 2015 and held it in 14 quarters. The position peaked at $640K in Q3 2025. 193 funds tracked by Wall St. Rank hold RIGL as of Q4 2025.

  • Dynamic Technology Lab reported no remaining Rigel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 22,600 Rigel Pharmaceuticals shares in Q4 2025, an estimated $640K.
  • Dynamic Technology Lab first reported a position in Rigel Pharmaceuticals in Q1 2015 and held it in 14 quarters.
  • Dynamic Technology Lab's Rigel Pharmaceuticals position peaked at $640K in Q3 2025.
  • 193 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2025.

Based on Dynamic Technology Lab's 13F filing for Q4 2025, filed 13 Feb 2026.